tiprankstipranks
Trending News
More News >
Tonix Pharmaceuticals (TNXP)
:TNXP
US Market
Advertisement

Tonix Pharma (TNXP) Ratios

Compare
4,900 Followers

Tonix Pharma Ratios

TNXP's free cash flow for Q2 2025 was $-0.64. For the 2025 fiscal year, TNXP's free cash flow was decreased by $ and operating cash flow was $-14.15. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
7.53 2.53 7.19 8.71 8.96
Quick Ratio
7.22 1.78 7.64 9.06 9.74
Cash Ratio
6.58 1.32 6.61 8.23 7.85
Solvency Ratio
-2.67 -2.30 -6.25 -4.16 -4.95
Operating Cash Flow Ratio
-3.40 -5.40 -5.39 -3.48 -4.95
Short-Term Operating Cash Flow Coverage
-332.53 -43.41 0.00 0.00 0.00
Net Current Asset Value
$ 124.18M$ -1.16M$ 112.27M$ 166.87M$ 77.45M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 0.06 <0.01 <0.01 0.01
Debt-to-Equity Ratio
<0.01 0.09 <0.01 <0.01 0.01
Debt-to-Capital Ratio
<0.01 0.09 <0.01 <0.01 0.01
Long-Term Debt-to-Capital Ratio
<0.01 0.06 0.00 0.00 0.00
Financial Leverage Ratio
1.12 1.46 1.09 1.10 1.12
Debt Service Coverage Ratio
-415.42 -48.55 0.00 0.00 0.00
Interest Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
<0.01 <0.01 0.00 0.00 0.00
Interest Debt Per Share
0.07 5.36 4.16 16.79 88.70
Net Debt to EBITDA
1.54 0.13 1.08 1.93 1.50
Profitability Margins
Gross Profit Margin
29.27%38.97%0.00%0.00%0.00%
EBIT Margin
-828.22%-1523.94%0.00%0.00%0.00%
EBITDA Margin
-823.99%-1468.70%0.00%0.00%0.00%
Operating Profit Margin
-838.00%-1523.94%0.00%0.00%0.00%
Pretax Profit Margin
-828.22%-1501.78%0.00%0.00%0.00%
Net Profit Margin
-540.64%-1501.78%0.00%0.00%0.00%
Continuous Operations Profit Margin
-828.22%-1501.78%0.00%0.00%0.00%
Net Income Per EBT
65.28%100.00%106.04%100.00%103.39%
EBT Per EBIT
98.83%98.55%98.33%99.97%99.90%
Return on Assets (ROA)
-28.37%-75.53%-51.79%-38.31%-53.14%
Return on Equity (ROE)
-37.82%-110.55%-56.41%-42.19%-59.53%
Return on Capital Employed (ROCE)
-48.95%-87.32%-54.02%-42.12%-57.16%
Return on Invested Capital (ROIC)
-48.89%-85.66%-56.25%-41.99%-56.70%
Return on Tangible Assets
-28.39%-81.15%-51.81%-38.33%-53.20%
Earnings Yield
-22.54%-4.94%-8.21%-0.71%-0.82%
Efficiency Ratios
Receivables Turnover
1.25 1.69 0.00 0.00 0.00
Payables Turnover
0.89 1.25 13.89 6.95 10.99
Inventory Turnover
1.16 0.34 -13.94 -11.95 -6.62
Fixed Asset Turnover
0.23 0.08 0.00 0.00 0.00
Asset Turnover
0.05 0.05 0.00 0.00 0.00
Working Capital Turnover Ratio
0.08 0.11 0.00 0.00 0.00
Cash Conversion Cycle
197.93 1.01K -52.46 -83.07 -88.34
Days of Sales Outstanding
292.27 215.67 0.00 0.00 0.00
Days of Inventory Outstanding
314.24 1.09K -26.19 -30.55 -55.11
Days of Payables Outstanding
408.57 291.17 26.27 52.52 33.23
Operating Cycle
606.50 1.30K -26.19 -30.55 -55.11
Cash Flow Ratios
Operating Cash Flow Per Share
-8.85 -55.69 -537.14 -1.33K -3.29K
Free Cash Flow Per Share
-8.92 -60.00 -800.90 -1.95K -3.87K
CapEx Per Share
0.07 4.31 263.75 620.11 579.43
Free Cash Flow to Operating Cash Flow
1.01 1.08 1.49 1.47 1.18
Dividend Paid and CapEx Coverage Ratio
-118.98 -12.92 -1.79 -2.14 -5.39
Capital Expenditure Coverage Ratio
-118.98 -12.92 -2.04 -2.14 -5.67
Operating Cash Flow Coverage Ratio
-131.79 -10.39 -129.02 -79.03 -37.05
Operating Cash Flow to Sales Ratio
-6.60 -13.13 0.00 0.00 0.00
Free Cash Flow Yield
-23.18%-4.65%-10.27%-0.85%-0.89%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-4.44 -20.25 -12.18 -141.24 -122.38
Price-to-Sales (P/S) Ratio
28.69 304.09 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
1.40 22.38 6.87 59.60 72.85
Price-to-Free Cash Flow (P/FCF) Ratio
-4.31 -21.49 -9.73 -117.57 -111.76
Price-to-Operating Cash Flow Ratio
-3.64 -23.16 -14.51 -172.51 -131.47
Price-to-Earnings Growth (PEG) Ratio
-0.04 -0.03 0.20 2.61 0.00
Price-to-Fair Value
1.40 22.38 6.87 59.60 72.85
Enterprise Value Multiple
-1.94 -20.57 -11.76 -139.35 -124.97
Enterprise Value
157.25M 2.35B 1.30B 12.86B 6.31B
EV to EBITDA
-1.94 -20.57 -11.76 -139.35 -124.97
EV to Sales
16.00 302.14 0.00 0.00 0.00
EV to Free Cash Flow
-2.40 -21.36 -8.92 -115.97 -110.44
EV to Operating Cash Flow
-2.43 -23.01 -13.30 -170.16 -129.91
Tangible Book Value Per Share
22.91 51.76 1.13K 3.84K 5.92K
Shareholders’ Equity Per Share
22.93 57.61 1.13K 3.84K 5.93K
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 -0.04 <0.01 <0.01
Revenue Per Share
1.34 4.24 0.00 0.00 0.00
Net Income Per Share
-7.25 -63.69 -640.26 -1.62K -3.53K
Tax Burden
0.65 1.00 1.06 1.00 1.03
Interest Burden
1.00 0.99 0.98 1.00 1.00
Research & Development to Revenue
3.63 11.16 0.00 0.00 0.00
SG&A to Revenue
1.37 4.47 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.43 1.19 0.00 0.00 0.00
Income Quality
0.80 0.87 0.89 0.82 0.96
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis